DEC 12, 2018 08:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Evolution in the Manufacturing of Cellular Therapies- lessons learned and current solutions

SPONSORED BY: Beckman Coulter
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Global BioPharma Manager - Cell and Gene Therapy Commercialization at Beckman Coulter
    Biography
      Neil Kayal has a long standing interest in the cellular manufacturing process with the overarching intent of democratization in personalized medication. He trained in Bioengineering and functional medical resonance imaging at Temple University with a focus on spinal cord injury in pediatric population. His research was on non-invasively quantifying healthy neuronal tissues as a pre-op to assist neurosurgeries. He later started a post-doctoral fellowship at the University of Michigan, investigating the cognitive-affective, psychosocial, and biological processes associated with the etiology and treatment of pathological aggression in patients with Intermittent Explosive Disorder by designing fMRI and DTI protocols and SPM8 analysis of clinical data. At Beckman Coulter, Neil Kayal manages the global biopharma business commercializing the life sciences portfolio in the cell and gene therapy market.

    Abstract:

    DATE: December 012, 2018
    TIME: 08:00 PST

    Immunotherapy is a powerful treatment that harnesses the body’s immune system in the fight against cancer. With optimized cell therapy, the result is an expanded population of T cells primed to recognize and eradicate malignant tumor cells that would otherwise escape immune detection. The webinar will discuss how cellular therapies have evolved, lessons learned through the evolution and current solutions available today.

    Learning Objectives:

    • Commercialization of manufacturing- preparing a CAR Garage, lessons learned and how does it impact the patient.
    • Automated functional testing- fully integrated unit operations taking the art out of science!

    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    MAY 24, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    MAY 29, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 29, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    Loading Comments...